Harvey's Garden

Benign liver tumors and hepatic cysts

Properties2
tags—
aliasesBenign liver tumors, hepatic cysts, hepatic hemangioma, Cavernous hemangioma

3 min read

Epidemiology

Frequency: hepatic hemangioma (most common) > focal nodular hyperplasia (FNH) > hepatocellular adenoma (rare)

Etiology

  • Hepatic Hemangioma: Most common benign liver lesion. F > M (usually age 30–50). Associated with pregnancy, estrogen use, and OCP use (can enlarge).
  • Focal Nodular Hyperplasia (FNH): Second most common benign liver lesion. Primarily in young females (F > M). Not strictly OCP-dependent (though can grow under hormonal influence).
  • Hepatic Adenoma: Strongly associated with OCP use and anabolic steroids. Also associated with glycogen storage diseases (e.g., Von Gierke). Young females (F >> M). c
  • Hepatocellular Carcinoma (HCC): Most common primary hepatic malignancy. Associated with cirrhosis (secondary to HCV, HBV, alcoholism, NASH), hemochromatosis, and aflatoxin B1 exposure.
  • Metastatic Disease: Most common liver malignancy overall. Usually secondary to primary malignancies of the colon, pancreas, lung, breast, or stomach.

Hepatic Adenoma

Epidemiology & Risk Factors

  • Predominantly young females (20-40yo).
  • Strong association with oral contraceptive pills (OCPs) (dose and duration-dependent).
  • Other risk factors:
    • Anabolic steroid use.
    • Glycogen storage diseases (type I and III).
    • Obesity and metabolic syndrome.

Clinical Features

  • Asymptomatic: Often found incidentally on imaging.
  • Symptomatic: Right upper quadrant (RUQ) pain or fullness due to mass effect or minor intratumoral hemorrhage.
  • Acute Rupture: Sudden-onset, severe RUQ pain, radiating to the right shoulder, signs of peritonitis, and hemorrhagic shock (hypotension, tachycardia) due to hemoperitoneum. c

Diagnosis

  • Initial Imaging: RUQ US (non-specific, well-demarcated echogenic mass).
  • Confirmatory/Gold Standard Imaging: Contrast-enhanced MRI of the liver (preferred over CT). Shows arterial enhancement with variable washout.
  • Key Labs:
    • AFP is normal (crucial to differentiate from HCC).
    • LFTs and liver function are typically normal.
  • Biopsy: Generally contraindicated due to high risk of bleeding/rupture and sampling error.

Management

  1. Discontinue OCPs (or offending steroids/medications) in all patients.
  2. Asymptomatic & Small (< 5 cm):
    • Conservative management.
    • Stop OCPs + serial imaging (MRI/US) every 6-12 months.
  3. Symptomatic, Large (≥ 5 cm), or Male patients:
    • Surgical resection (high risk of rupture and malignant transformation, especially in males).
  4. Pregnancy planning:
    • Resection recommended for tumors ≥ 5 cm prior to pregnancy due to high estrogen-induced risk of rupture during gestation.
  5. Ruptured/Unstable patient:
    • Hemodynamic resuscitation + urgent transcatheter arterial embolization (TAE) followed by elective resection of remaining tumor once stable.

Complications

  • Rupture & Hemorrhage: High risk during pregnancy (estrogen stimulates tumor growth) and if tumor is > 5 cm.
  • Malignant Transformation: Risk of progression to HCC (especially in males, β-catenin mutated subtypes, or large tumors).

Diagnostics

  • Ultrasonography: best initial test
  • Biopsy
    • Performed to confirm the diagnosis if imaging is inconclusive
    • Contraindicated in hepatic hemangiomas, as it may cause bleeding
    • Pathology
      • Hepatic hemangioma
        • Cavernous vascular spaces of variable size, lined by flat endothelial cells

Graph View

Backlinks